Literature DB >> 7780260

The presenting features of mucopolysaccharidosis type IH (Hurler syndrome).

M A Cleary1, J E Wraith.   

Abstract

The presenting features of 39 patients with mucopolysaccharidosis (MPS) type IH are described. The mean age at diagnosis was approximately 9 months and it is difficult to see how this can be reduced without consideration of newborn screening. An earlier age at diagnosis is likely to lead to better results following therapy such as bone marrow transplantation. Clinical features which should arouse suspicion of MPS IH include frequent ENT surgery and recurrent herniae. Clinical vigilance is needed for early diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7780260     DOI: 10.1111/j.1651-2227.1995.tb13640.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  23 in total

1.  Hand and foot abnormalities associated with genetic diseases.

Authors:  Henry J Mankin; Jesse Jupiter; Carol Ann Trahan
Journal:  Hand (N Y)       Date:  2010-10-26

2.  Rheumatologic aspects of lysosomal storage diseases.

Authors:  Bernhard Manger; Eugen Mengel; Roland M Schaefer
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

3.  Total hip arthroplasty in Hurler syndrome - 8 years follow up - A case report with review of literature.

Authors:  Deepak Gautam; Rajesh Malhotra
Journal:  J Orthop       Date:  2018-02-02

4.  Prevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantation.

Authors:  F J Stoop; M C Kruyt; M H van der Linden; R J B Sakkers; P M van Hasselt; R M C Castelein
Journal:  JIMD Rep       Date:  2012-09-19

5.  Synthetic zinc finger nuclease design and rapid assembly.

Authors:  Mark J Osborn; Anthony P DeFeo; Bruce R Blazar; Jakub Tolar
Journal:  Hum Gene Ther       Date:  2011-08-10       Impact factor: 5.695

Review 6.  Therapies for the bone in mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Adriana M Montaño; Hiromasa Yabe; Akemi Tanaka; Vu Chi Dung; Roberto Giugliani; Francyne Kubaski; Robert W Mason; Eriko Yasuda; Kazuki Sawamoto; William Mackenzie; Yasuyuki Suzuki; Kenji E Orii; Luis A Barrera; William S Sly; Tadao Orii
Journal:  Mol Genet Metab       Date:  2014-12-09       Impact factor: 4.797

7.  Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center.

Authors:  Kariman Abelin Genevois; Christophe Garin; Federico Solla; Nathalie Guffon; Rémi Kohler
Journal:  J Inherit Metab Dis       Date:  2013-06-29       Impact factor: 4.982

Review 8.  [Gaucher disease, Fabry disease and mucopolysaccharidosis type I--how can the rheumatologist recognise these patients?].

Authors:  B Manger; E Menge; R Schaefer; C Haase; J Seidel; H Michels
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

9.  Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I.

Authors:  Mark J Osborn; Ron T McElmurry; Christopher J Lees; Anthony P DeFeo; Zhi-Ying Chen; Mark A Kay; Luigi Naldini; Gordon Freeman; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2010-11-16       Impact factor: 11.454

10.  Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.

Authors:  Alice Pievani; Isabella Azario; Laura Antolini; Tsutomu Shimada; Pravin Patel; Cristina Remoli; Benedetta Rambaldi; Maria Grazia Valsecchi; Mara Riminucci; Andrea Biondi; Shunji Tomatsu; Marta Serafini
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.